Computed tomography imaging performed with an ultra-fast 320-detector scanner accurately assesses the need for cardiac angioplasty.
Computed tomography imaging performed with an ultra-fast 320-detector scanner accurately assesses the need for cardiac angioplasty, show results of a study presented today at the European Society of Cardiology Congress in Munich, Germany.
Researchers assessed the accuracy of testing used to determine the need for angioplasty among people who are having chest pain but not a heart attack. A total of 381 patients completed the study. They underwent traditional SPECT tests, invasive angiography, and two types of 320-detector CT exams: CTA, in which the scanner was used to visualize the vessel anatomy, and CTP, in which patients were tested with the same machine, but after they had been given a vasodilator.
The 320-detector CT scanner not only showed the anatomy of the blockages, but also whether the blockages were causing a lack of perfusion to the heart.
“We were therefore able to correctly identify the patients who needed revascularization within 30 days of their evaluation,” Carlos E. Rochitte, MD, a cardiologist at the Instituto do Coracao in Sao Paulo, Brazil, and lead author of the study said in a release.
“We found an excellent correlation in results when we compared the 320-detector CT testing with the traditional means of assessment using stress test with imaging and cardiac catheterization,” added Joao A. C. Lima, MD, a professor of medicine and radiology at the Johns Hopkins University School of Medicine and senior author.
The patients will be followed for up to five more years so researchers can track any heart-related events, hospital admissions, procedures and surgeries.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.